Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BR in Patients With CLL With Comorbidities and/or Renal Dysfunction

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT01832922
First received: April 12, 2013
Last updated: May 4, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2018
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)